If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Response to FCA Statement

28 Mar 2014 16:43

RNS Number : 5058D
Phoenix Group Holdings
28 March 2014
 



 

Phoenix Group Holdings ("Phoenix") response to FCA statement

 

 

Phoenix notes the statement issued by the FCA earlier today regarding a thematic review into the fair treatment of longstanding or legacy customers within closed life funds.

 

Although little detail has been provided regarding the scope and nature of any review, Phoenix makes the following observations:

 

· The FCA has stated that the review will not consider the suitability of historic advice, nor will it require a review of individual policies.

· The review will look at the level of servicing provided to policyholders whose policies are managed within closed life funds. Phoenix welcomes this review as we continue to look for areas where we can deliver better levels of customer service. We have achieved significant policy administration migrations to newer and better systems resulting in improved customer service. We regularly review our full product set to ensure it is operating as intended and remain committed to maintaining our focus on the governance of our products.

· Phoenix does not write new products (other than vesting annuities) and therefore we do not believe that any review of cross-subsidisation (in particular of the cost of new products) would be relevant to Phoenix.

· Furthermore, should the review look at the charging structures on historic policies, we are confident that our historic charging structures, including exit charges, have been compliant and in accordance with our commitments to our policyholders.

 

The press speculation regarding the thematic review follows two previous issues which have impacted the life assurance market over the last two weeks:

 

· The first of these issues was the announcement by the Chancellor in the Budget last week that policyholders would no longer be required to convert their pensions into an annuity on retirement. As explained in our full year results announcement, issued on Wednesday 26 March, we believe that this change will not have a material impact on Phoenix.

· Yesterday the Government announced a cap for all workplace pension schemes for auto enrolment. It is estimated that the cost of applying the cap to our schemes could have a maximum impact on our MCEV of £40 million.

 

In response to the statement from the FCA, Clive Bannister (Phoenix CEO) commented:

 

"Policyholders are central to everything that we do at Phoenix and we remain focussed on improving our performance and service. We aim to treat our policyholders fairly at all times. Operationally, we continue to streamline and modernise the business for the benefit of our policyholders. For example, in 2013 we increased the distributable estate by £565 million, with around 115,000 policyholders benefiting from £157 million of estate distributed in that year.

 

As our recent full-year results amply demonstrate, Phoenix is performing extremely well. This week we announced our highest ever cash generation (£817 million) and MCEV of £2.4 billion. We remain confident in the outlook for the Group.

 

We note that the review will not apply "current standards retrospectively" but is designed to "assess whether there is an issue that requires any action".

 

We will of course co-operate fully with any review conducted by the FCA."

 

We will update the market when we have greater clarity on the scope and nature of the review.

 

 

 

 

Enquiries

 

Investors / analysts

Sam Perowne

Head of Investor Relations, Phoenix Group

+44 (0)20 3735 0021

 

Media

Neil Bennett, Peter Ogden, Tom Eckersley,

Maitland

+44 (0)20 7379 5151

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRQKFDNABKDFNB
Date   Source Headline
7th Sep 20229:00 amRNSDirector/PDMR Shareholding
31st Aug 20225:00 pmRNSTotal Voting Rights
30th Aug 20224:30 pmRNSDirector/PDMR Shareholding
18th Aug 20225:00 pmRNSDirector/PDMR Shareholding
16th Aug 20224:30 pmRNSDirector/PDMR Shareholding
15th Aug 20227:00 amRNS2022 Half-Year Results
9th Aug 20224:30 pmRNSDirector/PDMR Shareholding
4th Aug 20227:00 amRNSPhoenix Group to acquire Sun Life UK
29th Jul 20224:00 pmRNSTotal Voting Rights
27th Jul 20223:45 pmRNSHolding(s) in Company
27th Jul 20223:31 pmRNSHolding(s) in Company
7th Jul 20224:45 pmRNSDirector/PDMR Shareholding
1st Jul 20222:00 pmRNSTotal Voting Rights
30th Jun 20224:30 pmRNSBlock Listing Return
29th Jun 20224:00 pmRNSBoard Changes Announcement
27th Jun 20223:15 pmRNSBlocklisting Application Announcement
9th Jun 20223:30 pmRNSDirector/PDMR Shareholding
31st May 20229:30 amRNSTotal Voting Rights
30th May 202211:00 amRNSBlock Listing Application
25th May 20223:00 pmRNSDirector/PDMR Shareholding
16th May 20224:30 pmRNSDirector/PDMR Shareholding
9th May 20223:00 pmRNSDirector/PDMR Shareholding
9th May 20222:15 pmRNSBoard Changes
5th May 20221:14 pmRNSResult of AGM
29th Apr 20225:00 pmRNSTotal Voting Rights
20th Apr 20226:30 pmRNSDirector/PDMR Shareholding
11th Apr 20226:00 pmRNSDirector/PDMR Shareholding
7th Apr 20224:45 pmRNSDirector/PDMR Shareholding
6th Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20225:00 pmRNSDirector/PDMR Shareholding
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20221:00 pmRNSTotal Voting Rights
30th Mar 20222:00 pmRNSDirector/PDMR Shareholding
25th Mar 20225:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20226:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:00 pmRNSNotice of AGM
16th Mar 20226:27 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNS2021 Annual Financial Report
9th Mar 202211:30 amRNSDirector/PDMR Shareholding
8th Mar 20225:00 pmRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
23rd Feb 20227:00 amRNSBoard Changes
11th Feb 20225:15 pmRNSDirector/PDMR Shareholding
11th Feb 202212:00 pmRNSDirector/PDMR Shareholding
9th Feb 20229:00 amRNSDirector/PDMR Shareholding
7th Feb 20222:30 pmRNSDirector/PDMR Shareholding
1st Feb 20222:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.